CaNCURE Trainees

Austin Barrett

Health Science, '18

Co-delivery of protective substrate and chemotherapy drugs via lipid Bilayer Mesoporous Silica Nanoparticles

Nicholas LoRocco

Biochemistry, '20

Quantitative Multimodal Imaging of Tumor Response to Radiation

Ann Marie Billig

Health Science, '18

miRNA analysis of up regulated miRNA-645 and miRNA-1290 in mouse orthotropic 4t1 model of metastatic breast cancer

Brian Cortese

Biochemistry, '19

Development of PSMA-targeting nanoparticles for positron emitting tomography imaging in prostate cancer using animal models

Gabby Brauner

Health Science, '18

Online monitoring and image-guided treatment of chemoresistant micrometastases

John Berrigan

Health Science, '18

Use of a Triblock Copolymer Hydrogel for Controlled Release of Cisplatin and BMN-673

Chris Li

Health Science, '18

The Assessment and Comparison of Ferumoxtran as Contrast Imaging Agent in Patients with Pancreatic Cancers.

Nicholas Martin

Health Sciences, '16

Pharmacokinetic analysis of changes in temozolomide distribution after antiangiogenic treatment of glioblastoma

Noelle Castilla Ojo

Behavioral Neurosci, '17

Localized chemo- and chemo-radiation for the treatment of prostate cancer

Oliver Cervantes

Biology, '16

Software with built-in neuroanatomy atlas provides insight into cancer treatment

Zoe Bishop

Biochemistry, '18

Small T Antigen Effect on Mitotic Proteins B-Myb and FOXM1

Vadim Molla

Health Sciences, '16

MCT1 Transporter Inhibition of IMR90 Cells Expressing Inducible Merkel Cell Carcinoma Small T Antigen

Soleil Doggett

Biology, '16

Erythropoietin improves antitumor immune response through reversal of the hypoxic tumor microenvironment

Thomas Hanlon

Health Sciences, '17

Uptake and localization of nanoparticles in prostate and lung cancer cells as a function of time and nanoparticle type

Sonali Rodrigues

Behavioral Neurosci., '16

Co-delivery of antibiotics and topoisomerase inhibitors to overcome chemoresistance

Sarah Sherman

Biology/English, '17

Tracking pancreatic adenocarcinoma response to treatment using targeted, multi-modal nanoparticles

Tom Licata

Health Sciences, '18

Protein-encapsulated nanoparticles for oral delivery of anti-mitotic agents in prostate cancer

Rachel Fontana

Biochemistry, '16

Capture of circulating tumor DNA through the use of biotinylated poly-lysine affixed to gold nanoparticles

Rowena Rajan

Cell and Molecular Bio, '18

Development of a novel nanogel for non-invasive transdermal delivery of cancer vaccines using hyaluronic acid

Zachary Silber

Health Science, '17

Combined delivery of targeted liposomal chemotherapeutics and photodynamic therapy to treat pancreatic cancer

Lucas Rohrer

Health Sciences, '17

Digital diffraction diagnostics for lymphoma and HPV

Dena Guo

Physics, '17

Longitudinal assessment of tumor heterogeneity during immunotherapy for metastatic melanoma

Craig Pille

Health Sciences, '16

Nano-plasmonic exosome (nPLEX) assays for exosome analysis and antibody validation

Deniz Ozisik

Biology/Math, '17

Biological mechanisms of gold nanoparticle-enhanced radiation therapy of prostate cancer

Grace Grifferty

Biochemistry, '18

Identification of novel therapeutic targets of the Notch1 signaling pathway

Jordan Harris

Chemical Engineering, '17

Surface-targeting, ligand-switching nanoparticles for mitochondrial drug delivery in prostate cancer

Jennifer Hayashi

Behavioral Neurosci, '17

Radiation enhancement in cancer cells using gold and gadolinium nanoparticles

Connor Elkhill

Biomedicial Physics, '17

Implementation of novel MR-based attenuation correction in PET/MR pelvic scans

Cicely Krebill

Biology, '19

Assessment of neoadjuvant therapy-induced atherosclerotic changes using ferumoxytol-enhanced MR imaging

Amanda Stroiney

Behavioral Neurosci., '16

Clinical immunotherapy application in metastatic glioblastoma

Alec Plotkin

Chemical Engineering, '18

Nanoencapsulation of tyrosine kinase inhibitors and their effects on pathway inhibition

Annie Bryant

Behavioral Neurosci, '19

Assessing the reproducibility of MRI-based brain tumor measurements between both observers and MRI vendors

Bryan Kynnap

Health Sciences, '16

Identifying genomic and compound dependencies in undifferentiated sarcomas

Bryce Delgado

Biochemistry, '18

Injectable thermogelling cisplatin-loaded hydrogels for combined chemo-radiation therapy in cervical cancer

Joseph Nneji

Biochemistry, '16

Quantification of SPION accumulation in tumors using positive-contrast MRI

Jeremy Thong

Nursing, '16

Combined Cisplatin and Olaparib nanoparticles for ovarian cancer therapy

Marisa Wozniak

Health Sciences, '18

Targeting WASp using Wiskostatin-gold nanoparticles

Julia Hannigan

Health Sciences, '16

Iron-chelating PEG-like nanoprobes as therapeutic and 89Zr/PET imaging agents

Meghan Jastrzembski

Health Sciences, '17

Investigating the use of iron chelator deferoxamine (DFO)-bearing PEG-like nanoprobes as a multifunctional agent for cancer therapy and PET imaging

Melissa Templeton

Health Sciences, '16

T1-weighted imaging of primary pancreatic adenocarcinoma using magnetic ferumoxytol nanoparticles

“I feel that the future of oncology research is in nanotechnology and nanomedicine. These  rapidly expanding areas of study have the potential to engineer incredibly precise solutions to scientific and medical problems.  Strides in these fields will allow us to create genetically customized treatments and therapies that can be delivered straight to the tumor.”

Sarah Sherman, Biology/English, ’17